CLDN3 and pancreatic neoplasm: For sensitivity testing of Cldn3/4 expressing pancreatic cancer cell lines toward recombinant CPE (recCPE) protein, increasing recCPE concentrations from 0 to 250 ng mL−1 were applied for 72 h and cytotoxicity was measured (Figure 1D).